News Category
Viromed Medical AG signs distribution agreements for its cold plasma device ViroCAP® in Spain, Portugal, Greece, the Balkans, Romania, and Saudi Arabi...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a significant step toward a potential neuroprotective therapy for mult...
PX1 Research introduces a domestically manufactured line of sublingual peptide strips for non-invasive research applications, potentially reshaping ho...
PX1 Research has expanded its US-based manufacturing to include seven-stage HPLC purity verification ensuring 99%+ purity on all research peptides, pr...
NanoViricides' regulatory approval to test its oral antiviral NV-387 in a Phase II Ebola trial in the DRC marks a potential shift toward more accessib...
New research from the University of Virginia suggests focused ultrasound could enhance drug delivery to gliomas, offering a less harmful alternative t...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in prostate and triple-negative breast can...
Park-Ohio's robust second-quarter performance and raised guidance indicate a favorable shift towards higher-margin businesses, despite ongoing losses ...
ICON Smile Studios expands with two flagship campuses in Virginia Beach and Norfolk, uniting orthodontics, periodontics, and pediatric dentistry under...
Scinai Immunotherapeutics strengthens its CDMO platform with the appointment of Eran Kuratz as head of supply chain and business process administratio...
Quantum BioPharma's FDA approval to advance Lucid-MS into Phase 2 trials marks a pivotal step toward a potential neuroprotective therapy for multiple ...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, driven by TONMYA's $11 million in sales, marking a significant commercial milestone an...
Tonix Pharmaceuticals' second-quarter revenue surged to $13.5 million, driven by TONMYA's $11 million in net sales, marking a significant commercial m...
Tonix Pharmaceuticals' strong Q2 2026 revenue, driven by TONMYA sales, underscores its commercial progress and financial stability, positioning it for...
Voyageur Pharmaceuticals' Mueller process has produced iodine at 99.8% purity and over 90% recovery in lab tests, with field pilot testing imminent, a...
OffScript introduces FOCUS+FLOW and CALM+COLLECTED mints with fully disclosed dosing and third-party testing, targeting the growing demand for clean-l...
A new narrative review in the World Journal of Pediatric Surgery provides a comprehensive framework for risk-adapted management of neuroblastoma, emph...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through clinical trials, regulatory submissions, and European comme...
Quantum BioPharma advances a two-pronged approach to neurological health, with Lucid-MS for multiple sclerosis and unbuzzd for alcohol misuse, highlig...
Quantum BioPharma advances a two-pronged approach to neurological health, combining its investigational MS therapy Lucid-MS with its supplement unbuzz...
VERAXA Biotech's proprietary BiTAC platform and pipeline of ADCs and T-cell engagers position it to capitalize on significant pharmaceutical investmen...
A Spanish patient's brain cancer scare was ultimately diagnosed as pork tapeworm cysts, underscoring the importance of proper pork preparation and the...
Veetee USA appoints Kevin Stitt to spearhead its retail growth at Walmart and Publix, leveraging its unique steam-cooked rice and upcoming Selma, NC f...
Lantern Pharma's upcoming Q2 2026 webcast will detail financial results and provide crucial updates on its AI-driven oncology pipeline and commercial ...
Earth Science Tech's strong quarterly results and strategic initiatives underscore its growth trajectory and potential for improved market visibility.
Thorium Atomics has initiated pre-application regulatory engagement with the U.S. Nuclear Regulatory Commission for its Tesseract TGR advanced reactor...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate program and expanded its patent portfolio, strengthening its position in ne...
American Fusion Inc. has filed six additional U.S. patent applications, bringing its total to 82, and is progressing toward OTCQB listing and next-pha...
Nano-X Imaging's $8 million registered direct offering with a long-term institutional investor signals continued confidence in its preventive healthca...
A novel liquid biopsy offers a simpler method to predict immunotherapy response in advanced lung cancer patients, potentially aiding clinical trials f...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA vaccine, positioning it for a pivotal P...
Innovative Designs, Inc. announces its best quarterly revenue in company history, with nearly 40% growth year-over-year and an eighth consecutive quar...
The July Wellness Index Report highlights a paradigm shift in longevity from overriding biology to working with the body's own hormones, cells, and mi...
The July Wellness Index Report reveals a paradigm shift in longevity toward working with the body's own hormones, cells, and microbiome, featuring thr...
Regentis Biomaterials' European approval for a next-generation GelrinC manufacturing process that boosts yield by 400% positions the cell-free hydroge...
Purple Exhibits announces expert oversight for all KBIS 2027 projects, ensuring specialized kitchen and bath industry guidance and quality control for...
Onco-Innovations' integrated approach combining PNKP-targeted DDR inhibition, nanoparticle delivery, and AI could improve cancer treatment efficacy an...
Earth Science Tech's strategic investments in technology and vertical integration position it to capitalize on the growing telehealth and peptide ther...
The latest DH Unplugged episode dissects volatile markets driven by Big Tech earnings, a Korean stock market crash, and SpaceX's post-IPO decline, hig...
Researchers at Nagoya University discovered that the ancient protein C3, when produced by tumor cells, boosts the effectiveness of immunotherapy, offe...
American Fusion Inc. presented its Texatron Fusion Engine development and Dr. Brandenburg's GEM Unification Theory at the APS DPF 2026 Meeting, advanc...
VolitionRx's new Capture-Seq technology, described in a peer-reviewed paper, isolates over 99% pure ctDNA, potentially enabling earlier cancer detecti...
Tonix Pharmaceuticals announced its participation in two key investor conferences, underscoring its commitment to advancing treatments for central ner...
VERAXA Biotech's VXA-222 bsADC program moves past discovery phase, and the company expands its IP portfolio with new patent filings, reinforcing its o...
LataMed AI Corp. will participate in an educational conference at Universidad Santa Maria to discuss the role of AI in healthcare and systems engineer...
NeuroThera Labs has initiated its Phase IIb clinical trial for SCI-110, a novel cannabinoid-based treatment for Tourette Syndrome, at the Yale Child S...
Medios AG has appointed Katrin Neuffer to lead its investor relations and communications, succeeding Claudia Nickolaus, as the company aims to strengt...
SRX Global's strategic investment in Vistagen Therapeutics underscores its commitment to unlocking shareholder value in undervalued biopharmaceutical ...
